A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • OBJECTIVE: To determine whether glargine is noninferior to detemir regarding the percentage of patients reaching A1C <7% without symptomatic hypoglycemia

authors

  • Swinnen, SG
  • Dain, M.-P
  • Aronson, R
  • Davies, M
  • Gerstein, Hertzel Chaim
  • Pfeiffer, AF
  • Snoek, FJ
  • DeVries, JH
  • Hoekstra, JB
  • Holleman, F

publication date

  • June 1, 2010